Search Results for medicines

Biocytogen Enhances Preclinical Services and Unveils Redesigned Global Website

Biocytogen Elevates Preclinical Research Services and Global Engagement with Strategic Platform Upgrade and Website Relaunch Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKEX: 02315), a pioneering force in the biotechnology sector known for its cutting-edge antibody discovery and preclinical services, has taken…

Read MoreBiocytogen Enhances Preclinical Services and Unveils Redesigned Global Website

MaaT Pharma Secures €37.5M EIB Loan to Advance Hemato-Oncology Program

MaaT Pharma Secures €37.5 Million EIB Loan to Propel Hemato-Oncology Pipeline and Microbiome Therapy Leadership MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotechnology company pioneering Microbiome Ecosystem Therapies™ (MET) to improve survival outcomes in cancer patients through immune modulation, announced a…

Read MoreMaaT Pharma Secures €37.5M EIB Loan to Advance Hemato-Oncology Program

Alloy Therapeutics and KSAC Partner to Boost Global Growth of Japanese Biotech Startups

Alloy Therapeutics and KSAC Forge Strategic Alliance to Propel Global Growth of Japanese Life Science Startups Alloy Therapeutics Co. Ltd. (“Alloy Japan”) has entered into a strategic Memorandum of Understanding (MOU) with the Kansai Startup Academia Coalition (KSAC), an initiative…

Read MoreAlloy Therapeutics and KSAC Partner to Boost Global Growth of Japanese Biotech Startups

WuXi Biologics Gets FDA Nod for Five Sites, Including First Commercial PFS Line

WuXi Biologics Achieves Major Regulatory Milestone with FDA Pre-License Inspection Clearance for Five Facilities, Including First Commercial Pre-Filled Syringe Site WuXi Biologics (HKEX: 2269), a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO) services, has reached a significant…

Read MoreWuXi Biologics Gets FDA Nod for Five Sites, Including First Commercial PFS Line

Bristol Myers’ sNDA for Sotyktu in Psoriatic Arthritis Accepted in Four Global Regions

Bristol Myers Squibb’s Sotyktu Makes Global Regulatory Progress for Psoriatic Arthritis as FDA Accepts sNDA for Review In a major development for immunology-focused therapeutics, Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has…

Read MoreBristol Myers’ sNDA for Sotyktu in Psoriatic Arthritis Accepted in Four Global Regions

Fresenius Kabi Honored with 2025 Premier Supplier Legacy Award for Longstanding Excellence

Fresenius Kabi Honored with 2025 Premier Supplier Legacy Award for Continued Excellence in Healthcare Delivery Fresenius Kabi, a leading global healthcare company specializing in lifesaving medicines and technologies, has once again been recognized for its longstanding commitment to excellence in…

Read MoreFresenius Kabi Honored with 2025 Premier Supplier Legacy Award for Longstanding Excellence